Source: United Press International
Posted: April 14, 2006
Aldagen has been cleared to start a clinical trial using stem cells to develop a treatment for critical limb ischemia (CLI), a severe form of peripheral vascular disease (PVD). Scientists say the disorder is currently treated with either percutaneous or surgical revascularization, which carries a high mortality risk,
No comments:
Post a Comment